ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Clinical Practice Session

Management of Traditional Cardiovascular Risk Factors in Patients with ESKD

November 04, 2021 | 10:30 AM - 12:30 PM

Location: Live-Stream, Virtual Only

Session Description

CVD is an important contributor to morbidity and mortality in ESKD, but evidence supporting the management of CVD risk factors in ESKD is scarce. The complexity of ESKD care requiring management of multiple comorbidities can result in polypharmacy and adverse drug reactions. Therefore, it is crucial to understand which therapies targeting CVD risk factors are evidence-based and indicated in ESKD. This session reviews the latest developments in goals and treatment approaches for hypertension, diabetes, and dyslipidemia in patients with ESKD.

Learning Objective(s)

  • Describe the importance of the accurate assessment of CVD risk factors, including BP, glycemia, and lipid levels in patients with ESKD
  • Discuss ESKD-specific factors that affect the treatment of traditional CVD risk factors
  • Report the latest recommendations for treatment and attained goals in the management of hypertension, diabetes, and dyslipidemia in patients with ESKD

Learning Pathway(s)

  • Dialysis
  • Hypertension and CVD

Moderators

  • Ian H. de Boer, MD, MS
  • Keiichi Sumida, MD, PhD, MPH, FASN

Presentations

  • Selection of Antihypertensive Drug Therapy in ESKD
    10:30 AM - 11:00 AM
    Elvira O. Gosmanova, MD, FASN
  • Balancing Diabetes Control in ESKD
    11:00 AM - 11:30 AM
    Connie Rhee, MD, MS
  • Hyperlipidemia in Dialysis: Treat or Don't Treat?
    11:30 AM - 12:00 PM
    Roy O. Mathew, MD, FASN
  • Peripheral Artery Disease in ESKD: Not a Peripheral Issue
    12:00 PM - 12:30 PM
    Kunihiro Matsushita, MD, PhD